Dr. Nazlı Ezgi Özkan-Küçük holds a bachelor’s degree from Istanbul University in Molecular Biology and Genetics. She then obtained her master’s degree in Molecular Medicine from Istanbul University, Experimental Medicine Research Institute.

Selected Publications

Özkan Küçük N.E, Şanal E, Tan E, Mitchison T, Özlü N. Labeling Carboxyl Groups of Surface-Exposed Proteins Provides an Orthogonal Approach for Cell Surface Isolation. J Proteome Res, 2018. 17(5): p. 1784-1793.

Üretmen Kagıalı ZC, Şentürk A, Özkan Küçük NE, Qureshi MH, Özlü N. Proteomics in Cell Division. Proteomics. 2017 Oct;17(20). doi: 10.1002/pmic.201600100. Epub 2017 Sep 4. Review.

Özlü N, Qureshi MH, Toyoda Y, Renard BY, Mollaoglu G, Özkan NE, Bulbul S, Poser I, Timm W, Hyman AA, Mitchison TJ, Steen JA. Quantitative comparison of a human cancer cell surface proteome between interphase and mitosis. EMBO J. 2015 Jan 13;34(2):251-65.

Timirci-Kahraman Ö, Verim A, Farooqi AA, Turan S, Özkan-Küçük NE, Yaylim İ. Expression of miR-373 and its predicted target genes E-cadherin and CD44 in patients with laryngeal squamous cell carcinoma. Cell Mol Biol (Noisy-le-grand). 2017 Dec 30;63(12):29-33.

Yanar K, Çakatay U, Aydın S, Verim A, Atukeren P, Özkan NE, Karatoprak K, Cebe T, Turan S, Ozkök E, Korkmaz G, Cacına C, Küçükhüseyin O, Yaylım İ. Relation between Endothelial Nitric Oxide Synthase Genotypes and Oxidative Stress Markers in Larynx Cancer. Oxid Med Cell Longev. 2016;2016:4985063.

Karakose Okyaltırık F, Rezvani A, Turan S, Uysal Ö, Yakar F, Sozgen H, Ozkan NE, Akkoyunlu ME, Bayram M, Kutbay Ozcelik H, Sezer M, Guler M, Yaylım İ, Kart L. Relationship of CTLA4 and CD28 polymorphisms with lung involvement, HRCT findings and pulmonary function tests in Turkish patients with ankylosing spondylitis. Clin Respir J. 2015 Sep 14.

Timirci-Kahraman O, Ozkan NE, Turan S, Farooqi AA, Verim L, Ozturk T, Inal-Gultekin G, Isbir T, Ozturk O, Yaylim I.Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer. Genet Test Mol Biomarkers. 2015 Jun;19(6):309-15.

Verim A, Turan S, Farooqi AA, Kahraman OT, Tepe-Karaca C, Yildiz Y, Naiboglu B, Ozkan NE, Ergen A, Isitmangil GA, Yaylim I. Association between laryngeal squamous cell carcinoma and polymorphisms in tumor necrosis factor related apoptosis induce ligand (TRAIL), TRAIL receptor and sTRAIL levels. Asian Pac J Cancer Prev. 2014;15(24):10697-703.

Farooqi AA, Yaylim I, Ozkan NE, Zaman F, Halim TA, Chang HW. Restoring TRAIL mediated signaling in ovarian cancer cells. Arch Immunol Ther Exp (Warsz). 2014 Dec;62(6):459-74.

Zeybek U, Yaylim I, Ozkan NE, Korkmaz G, Turan S, Kafadar D, Cacina C, Kafadar AM. Cyclin D1 gene G870A variants and primary brain tumors. Asian Pac J Cancer Prev. 2013;14(7):4101-6.

Verim L, Toptas B, Ozkan NE, Cacina C, Turan S, Korkmaz G, Yaylim I. Possible relation between the NOS3 gene GLU298ASP polymorphism and bladder cancer in Turkey. Asian Pac J Cancer Prev. 2013;14(2):665-8.

Yaylim I, Ozkan NE, Isitmangil T, Isitmangil G, Turna A, Isbir T. CK2 enzyme affinity against c-myc 424-434 substrate in human lung cancer tissue. Asian Pac J Cancer Prev. 2012;13(10):5233-6.